Heart Test Laboratories Q2 2025 Earnings Report $3.49 +0.02 (+0.61%) As of 01/21/2025 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Earnings HistoryForecast Heart Test Laboratories EPS ResultsActual EPS-$2.27Consensus EPS -$2.30Beat/MissBeat by +$0.03One Year Ago EPS-$15.92Heart Test Laboratories Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AHeart Test Laboratories Announcement DetailsQuarterQ2 2025Date12/16/2024TimeAfter Market ClosesConference Call ResourcesHSCS Earnings History Heart Test Laboratories Earnings HeadlinesAdvanced BioMedical Technologies (OTCMKTS:ABMT) and Heart Test Laboratories (NASDAQ:HSCS) Head-To-Head ComparisonJanuary 18, 2025 | americanbankingnews.comHeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial ResultsDecember 16, 2024 | globenewswire.comA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. January 22, 2025 | Porter & Company (Ad)HeartSciences Inc. HSCS (U.S.: Nasdaq)November 23, 2024 | wsj.comHeart Test announces CMS included AI-ECG tech in 2025 OPPS final ruleNovember 14, 2024 | markets.businessinsider.comHeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid ReimbursementNovember 13, 2024 | globenewswire.comSee More Heart Test Laboratories Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Heart Test Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heart Test Laboratories and other key companies, straight to your email. Email Address About Heart Test LaboratoriesHeart Test Laboratories (NASDAQ:HSCS), a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.View Heart Test Laboratories ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings Abbott Laboratories (1/22/2025)Amphenol (1/22/2025)GE Vernova (1/22/2025)ICICI Bank (1/22/2025)Johnson & Johnson (1/22/2025)Kinder Morgan (1/22/2025)Procter & Gamble (1/22/2025)Progressive (1/22/2025)Travelers Companies (1/22/2025)CSX (1/23/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
